A Phase 2b Randomized, Double Blinded, MultiCenter Trial

Project: Research project

Project Details

Description

A Phase 2 Randomized, Double Blinded, Multi-Center Trial of Amplimexon plus Gemcitabine vs Gemcitabine plus Placebo in Patients with Metastic Chemotherapy Naive Pancreatic Adenocarcinoma (Stage IV)
StatusFinished
Effective start/end date1/6/0910/30/10

Funding

  • AmpliMed Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.